According to OptiNose's latest financial reports the company's current revenue (TTM) is $74.02 M. In 2022 the company made a revenue of $76.27 M an increase over the years 2021 revenue that were of $74.65 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $70.98 M | -6.93% |
2022 | $76.27 M | 2.18% |
2021 | $74.65 M | 51.99% |
2020 | $49.11 M | 41.83% |
2019 | $34.63 M | 390.25% |
2018 | $7.06 M | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.79 B | 980.22% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.69% | ๐บ๐ธ USA |